- 25371 Commercentre Dr, Lake Forest, CA 92630
- Patients Results
A liquid biopsy is a test that looks for cancer-related material in the blood. According to GTC’s patient page, it looks for DNA/RNA released by the tumor into the bloodstream, which can provide insights that may be similar to information gained from a tissue sample.
Unlike traditional biopsy procedures or bone marrow biopsy, a liquid biopsy may be performed from a blood draw, which makes it a less invasive option for some patients. GTC specifically describes it as a less invasive alternative for tumor profiling and monitoring.
Yes. GTC’s page says liquid biopsies can be useful for monitoring response to treatment and for ongoing surveillance to detect whether a relapse has occurred.
Not always. The page presents liquid biopsy as a useful alternative in selected situations, especially when a patient cannot undergo a biopsy procedure or when a less invasive way of monitoring is needed.
For many patients, one of the biggest advantages of a liquid biopsy is simplicity. Instead of relying on a more invasive procedure, the test may begin with a standard blood draw. That can make the process feel more manageable, especially for patients who need ongoing monitoring, who may not be good candidates for a traditional biopsy, or who want to avoid additional discomfort when an appropriate blood-based option is available. GTC’s patient page specifically positions liquid biopsy as a less invasive approach for profiling and monitoring cancer.
GTC’s Liquid Trace® testing is part of its liquid biopsy offering and is positioned within the site as a dedicated category for both solid tumor and hematology applications. On the patient page, GTC explains that the liquid biopsy process uses advanced DNA/RNA sequencing technology to look for cancer-related material circulating in the blood, and that the results are analyzed before a report is returned to the treating physician. In practical terms, this means a blood-based sample may help provide useful molecular insight to support cancer detection, profiling, and monitoring in appropriate clinical settings.
The process begins with a blood sample from the patient.
The sample is sent to the laboratory, where advanced DNA/RNA sequencing is used to look for cancer-related material in the blood.
The findings are analyzed and then returned to the physician in a report that may offer insight into the tumor and therapies that may be effective.
Because it uses a blood draw instead of a more invasive biopsy procedure, a liquid biopsy may feel simpler, easier, and less stressful for some patients. In appropriate cases, it can offer a more patient-friendly way to gather important molecular information.
A liquid biopsy may help with cancer detection, molecular profiling, treatment monitoring, and follow-up over time. This means it can play a role not only at diagnosis, but also during treatment and ongoing surveillance.
For some patients, a traditional biopsy may be difficult, risky, or not easily possible. In these situations, a liquid biopsy may provide an alternative way to obtain meaningful information through a less invasive approach.
A liquid biopsy can provide valuable information, but the best testing approach depends on the type of cancer, the clinical situation, and the goals of care. Your physician will determine whether liquid biopsy is the right option and how it should be used as part of your overall treatment plan.
For patients, a liquid biopsy may offer a more comfortable and less invasive way to gather meaningful information about cancer. By using a blood sample to look for tumor-related DNA/RNA and support profiling, monitoring, and follow-up, GTC offers liquid biopsy and its Liquid Trace® approach,as a practical option that can help bring more clarity with less burden in appropriate cases.
